Calibre Scientific has announced the acquisition of Linaris Biologische Produkte, a life science distributor with headquarters outside of Frankfurt, Germany. It will be integrated with Biozol Diagnostica, enhancing its sales capabilities and product range for customers in the region.
Linaris is a distributor which offers antibodies, proteins, ELISA kits, and reagents. Its customers include researchers from German universities, hospitals, research institutes, pathology labs, and pharma and biotech companies.
With this acquisition, Biozol has enhanced its position in the German research and diagnostics market, it says, as Linaris will bring supplier relationships and product expertise to complement Biozol’s current capabilities. “We are very excited about this acquisition,” said Jonas Bäuerle, MD of Biozol. “With Linaris, we will expand our catalogue of high-quality life science products and introduce them to our broad customer base, to further solidify our position as the premier independent distribution platform in the DACH region for the world’s leading manufacturers.”
Dr Peter Harbarth, MD & CEO of Linaris said: “Calibre Scientific has built a unique platform in the life science and diagnostics space: with this transition, I have the utmost confidence that the company I founded three decades ago will be in good hands for decades to come. Biozol has deep expertise in our market, and I trust them to carry on my mission of providing excellent products and service to our customers.”